Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.240
-0.070 (-5.34%)
At close: Sep 11, 2026, 4:00 PM EDT
1.220
-0.020 (-1.61%)
After-hours: Sep 11, 2026, 8:00 PM EDT
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $3.22 million as of September 11, 2026. Its market cap has decreased by -63.68% in one year.
Market Cap
3.22M
Enterprise Value
1.09M
1-Year Change
-63.68%
Ranking
Category
Stock Price
$1.24
ChartMarket Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.83M to $3.22M, a decrease of -98.83%. That is a compound annual growth rate of -59.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 3.22M | -62.44% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.45M | -64.38% |
| Dec 30, 2021 | 282.03M | 3.00% |
| Nov 1, 2021 | 273.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 3.59M |
| CDT Equity | 3.54M |
| GeoVax Labs | 3.44M |
| Silo Pharma | 3.41M |
| BioRestorative Therapies | 3.40M |
| Aptevo Therapeutics | 3.33M |
| 60 Degrees Pharmaceuticals | 3.27M |
| SciSparc | 3.02M |